Opicapone (Ongentys) is a new once‐daily catechol‐O‐methyl transferase (COMT) inhibitor with a long duration of action allowing once‐daily dosing, lice... Steve,Chaplin - 《Prescriber》 被引量: 0发表: 2017年 Opicapone: A third generation COMT Inhibitor Objective To provide a drug review ...
TIME/ACTION PROFILE (plasma concentrations) ROUTEONSETPEAKDURATION POunknown2 hrunknown Contraindication/Precautions Contraindication/Precautions Contraindication/Precautions Contraindicated in: Concurrent use of nonselective MAO inhibitors; Pheochromocytoma, paraganglioma, or other catecholamine secreting neoplasms ...
TIME/ACTION PROFILE (plasma concentrations) ROUTEONSETPEAKDURATION POunknown2 hrunknown Contraindication/Precautions Contraindication/Precautions Contraindication/Precautions Contraindicated in: Concurrent use of nonselective MAO inhibitors; Pheochromocytoma, paraganglioma, or other catecholamine secreting neoplasms ...
Opicapone (Ongentys) is a new once‐daily catechol‐O‐methyl transferase (COMT) inhibitor with a long duration of action allowing once‐daily dosing, licensed for adjunctive therapy in adults with Parkinson's disease and end‐of‐dose m... Steve,Chaplin - 《Prescriber》 被引量: 0发表: 2017...